Pediatric Primary Care Case Studies (140 page)

Claritin.
See
loratadine (Claritin)

clavulanate.
See
amoxicillin/clavulanate (Augmentin)

Cleocin.
See
clindamycin (Cleocin)

clindamycin (Cleocin),
353
–354,
353
t,
356
t,
474
t–477t

clinical trials and studies

American Community Survey,
225

Bogalusa Heart Study,
272
–273

DCCT,
274
–275

ERIC,
274

Kinsey Institute studies,
225
–226

NHANES,
88

SEARCH for Diabetes in Youth Study,
272
–274

TADS,
213

TODAY Study,
277

TRIGR study,
273
–274

cluster headache,
322
,
324
–328.
See also
headache

CMV (cytomegalovirus),
235
–237

CNDC (chronic nonspecific diarrhea of childhood),
391
–392

COC (combined oral contraceptive) pills,
435
b–437b

cognitive behavior therapy.
See
CBT (cognitive behavior therapy)

combined oral contraceptive pills.
See
COC (combined oral contraceptive) pills

complete blood counts.
See
CBCs (complete blood counts)

congenital hip dysplasia.
See
CHD (congenital hip dysplasia)

Conners’ Scales,
180
–181

consciousness loss,
359
–376

case presentation for,
360
,
366
–368,
370
,
372
–373

diagnosis of,
363
–373

ECGs,
370

emergent evaluations,
370
,
371
f

history-taking,
363
–367

imaging studies,
370

laboratory blood work,
369
–370

physical examinations,
367
–368

red flags,
364
–365

epidemiology/etiology of,
360
–361,
361
t

causal factors,
360
–361,
361
t

definitions,
360

recurrent episodes,
363

fundamental contexts of,
359
–360,
374

management of,
372
–373

best practice evidence,
372
–373

referral
vs
. admission indictors,
372

objectives for,
359

resources for,
374
–375

constipation (school-age children),
115
–132

case presentation for,
115
–116,
119
,
122
–123,
126
,
128

encopresis,
115
–130

diagnostic testing for,
120
–121

epidemiology/etiology of,
116
–117,
117
–118

follow-up visits for,
126
,
130

history-taking for,
118
–119

management of,
124
t–125t,
126
–130,
129
t

medications for,
124
t–125t,
129
t

parental education for,
127
–128

physical examinations for,
120
–122

prognosis for,
130

Rome III criteria for,
117
t

fundamental contexts of,
115
–116,
130
–131

objectives for,
115

resources for,
131
–132

contact dermatitis,
459

contraception (adolescents),
427
–440

case presentation for,
427
–428,
434
,
437
–439

diagnosis of,
428
–430

diagnostic testing,
428

history-taking,
429
–430

physical examination,
428

fundamental contexts of,
427
,
439

management of,
430
–439

COC pills,
435
b–437b

counseling,
437
–438

follow-up visits,
438
–439

options,
430
–434,
431
t

objectives for,
427

resources for,
439
–440

corticosteroids

inhaled,
260

oral,
473

topical,
460
–461,
461
t

cough,
377
–386

case presentation for,
377
–378,
381
,
383
–384

diagnosis of,
378
–383

clinical manifestations,
380

common pneumonia syndromes,
382
t

diagnostic testing,
382
–383

differential,
380
–381

history-taking,
378
–379

Mycoplasma pneumoniae
,
377
–385

physical examination,
381
–382

pneumonia,
378
–383

epidemiology/etiology of,
378
–380

common pathogens,
379
t

pathophysiology,
378
–379

fundamental contexts of,
377
–385

management of,
383
–385

educational plans,
384

follow-up visits,
384

hospitalization
vs
. home care,
383

medications,
383
–385

pathogen transmission,
384
–395

prognosis,
384
–395

objectives for,
377

resources for,
385

CP (cerebral palsy),
19
–20

critical thinking skills,
1
–8

best evidence
vs
. best practice and,
1
,
5

care models and,
5

caregiving teams and,
5
–6

complicating contexts of,
3
–5